Viking Therapeutics (VKTX) Misses Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Viking Therapeutics (VKTX) Misses Q2 EPS by 2c

Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

August 1, 2019 4:05 PM EDT

SAN DIEGO, Aug. 1, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the second quarter ended June 30, 2019, and provided an update on its clinical pipeline and other corporate developments.

... More